13F HOLDINGS REPORT
DIADEMA PARTNERS LP
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001892688-25-000116
Total Value
$383.3M
Positions
102
Other Managers
0
Confidential Omitted
No
Holdings (102)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AMGEN INC | AMGN | 103,300 | $32.2M | 8.40% |
| 2 | PFIZER INC | PFE | 900,000 | $22.8M | 5.95% |
| 3 | REGENERON PHARMACEUTICALS | REGN | 29,828 | $18.9M | 4.94% |
| 4 | CORCEPT THERAPEUTICS INC | CORT | 150,200 | $17.2M | 4.48% |
| 5 | ELI LILLY & CO | LLY | 20,700 | $17.1M | 4.46% |
| 6 | AMGEN INC | AMGN | 52,100 | $16.2M | 4.24% |
| 7 | ELI LILLY & CO | LLY | 19,302 | $15.9M | 4.16% |
| 8 | SOLENO THERAPEUTICS INC | SLNO | 219,400 | $15.7M | 4.09% |
| 9 | SOLENO THERAPEUTICS INC | SLNO | 217,000 | $15.5M | 4.05% |
| 10 | REGENERON PHARMACEUTICALS | REGN | 20,000 | $12.7M | 3.31% |
| 11 | JAZZ PHARMACEUTICALS PLC | JAZZ | 87,189 | $10.8M | 2.82% |
| 12 | JAZZ PHARMACEUTICALS PLC | JAZZ | 70,800 | $8.8M | 2.29% |
| 13 | NOVO-NORDISK A S | NONOF | 124,600 | $8.7M | 2.26% |
| 14 | ELI LILLY & CO | LLY | 10,000 | $8.3M | 2.15% |
| 15 | TG THERAPEUTICS INC | TGTX | 207,883 | $8.2M | 2.14% |
| 16 | NOVO-NORDISK A S | NONOF | 108,700 | $7.5M | 1.97% |
| 17 | ARGENX SE | ARGX | 12,279 | $7.2M | 1.87% |
| 18 | NEUROCRINE BIOSCIENCES INC | NBIX | 62,247 | $6.9M | 1.80% |
| 19 | SOLENO THERAPEUTICS INC | SLNO | 93,002 | $6.6M | 1.73% |
| 20 | ALNYLAM PHARMACEUTICALS INC | ALNY | 20,000 | $5.4M | 1.41% |
| 21 | APOGEE THERAPEUTICS INC | APGE | 126,300 | $4.7M | 1.23% |
| 22 | CORCEPT THERAPEUTICS INC | CORT | 40,000 | $4.6M | 1.19% |
| 23 | BRIDGEBIO PHARMA INC | BBIO | 131,400 | $4.5M | 1.19% |
| 24 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 123,300 | $4.5M | 1.16% |
| 25 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 117,000 | $4.2M | 1.11% |
| 26 | CRISPR THERAPEUTICS AG | CRSP | 112,000 | $3.8M | 0.99% |
| 27 | BIOMARIN PHARMACEUTICAL INC | BMRN | 52,877 | $3.7M | 0.98% |
| 28 | RECURSION PHARMACEUTICALS IN | RXRX | 698,400 | $3.7M | 0.96% |
| 29 | ALNYLAM PHARMACEUTICALS INC | ALNY | 13,115 | $3.5M | 0.92% |
| 30 | AGIOS PHARMACEUTICALS INC | AGIO | 119,700 | $3.5M | 0.92% |
| 31 | VAXCYTE INC | PCVX | 92,385 | $3.5M | 0.91% |
| 32 | IMMUNOCORE HLDGS PLC | IMCR | 96,984 | $2.9M | 0.75% |
| 33 | MODERNA INC | MRNA | 100,000 | $2.8M | 0.74% |
| 34 | RHYTHM PHARMACEUTICALS INC | RYTM | 50,000 | $2.6M | 0.69% |
| 35 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 60,000 | $2.6M | 0.69% |
| 36 | MANNKIND CORP | MNKD | 519,900 | $2.6M | 0.68% |
| 37 | VIKING THERAPEUTICS INC | VKTX | 104,121 | $2.5M | 0.66% |
| 38 | CENTESSA PHARMACEUTICALS PLC | CNTA | 164,048 | $2.4M | 0.62% |
| 39 | COGENT BIOSCIENCES INC | COGT | 392,213 | $2.3M | 0.61% |
| 40 | VIRIDIAN THERAPEUTICS INC | VRDN | 162,063 | $2.2M | 0.57% |
| 41 | ANAPTYSBIO INC | ANABV | 117,300 | $2.2M | 0.57% |
| 42 | EDGEWISE THERAPEUTICS INC | EWTX | 98,200 | $2.2M | 0.56% |
| 43 | ZYMEWORKS INC | ZYME | 179,300 | $2.1M | 0.56% |
| 44 | ALTIMMUNE INC | ALT | 418,800 | $2.1M | 0.55% |
| 45 | VAXCYTE INC | PCVX | 51,600 | $1.9M | 0.51% |
| 46 | SCHOLAR ROCK HLDG CORP | SRRK | 57,923 | $1.9M | 0.49% |
| 47 | ANAPTYSBIO INC | ANABV | 96,800 | $1.8M | 0.47% |
| 48 | 89BIO INC | 282559103 | 231,436 | $1.7M | 0.44% |
| 49 | NOVO-NORDISK A S | NONOF | 24,618 | $1.7M | 0.44% |
| 50 | UNIQURE NV | QURE | 154,100 | $1.6M | 0.43% |
| 51 | KALVISTA PHARMACEUTICALS INC | KALV | 135,509 | $1.6M | 0.41% |
| 52 | KEROS THERAPEUTICS INC | KROS | 147,100 | $1.5M | 0.39% |
| 53 | APOGEE THERAPEUTICS INC | APGE | 40,000 | $1.5M | 0.39% |
| 54 | MODERNA INC | MRNA | 52,100 | $1.5M | 0.39% |
| 55 | SAGE THERAPEUTICS INC | 78667J108 | 183,466 | $1.5M | 0.38% |
| 56 | VISTAGEN THERAPEUTICS INC | VTGN | 565,975 | $1.4M | 0.37% |
| 57 | ASCENDIS PHARMA A/S | ASND | 8,321 | $1.3M | 0.34% |
| 58 | VIKING THERAPEUTICS INC | VKTX | 50,000 | $1.2M | 0.32% |
| 59 | COGENT BIOSCIENCES INC | COGT | 201,400 | $1.2M | 0.31% |
| 60 | KALVISTA PHARMACEUTICALS INC | KALV | 103,300 | $1.2M | 0.31% |
| 61 | MEREO BIOPHARMA GROUP PLC | MREO | 515,200 | $1.2M | 0.30% |
| 62 | TREVI THERAPEUTICS INC | TRVI | 180,000 | $1.1M | 0.30% |
| 63 | RELAY THERAPEUTICS INC | RLAY | 426,346 | $1.1M | 0.29% |
| 64 | AMICUS THERAPEUTICS INC | FOLD | 131,400 | $1.1M | 0.28% |
| 65 | OCULAR THERAPEUTIX INC | OCUL | 136,700 | $1.0M | 0.26% |
| 66 | PACIRA BIOSCIENCES INC | PCRX | 38,926 | $967,311 | 0.25% |
| 67 | GOSSAMER BIO INC | GOSS | 824,800 | $907,280 | 0.24% |
| 68 | UROGEN PHARMA LTD | URGN | 76,220 | $842,993 | 0.22% |
| 69 | CLIMB BIO INC | CLYM | 669,803 | $817,160 | 0.21% |
| 70 | CYTOKINETICS INC | CYTK | 20,000 | $803,800 | 0.21% |
| 71 | REPLIMUNE GROUP INC | REPL | 74,530 | $726,668 | 0.19% |
| 72 | KEROS THERAPEUTICS INC | KROS | 65,800 | $670,502 | 0.17% |
| 73 | CARDIFF ONCOLOGY INC | CRDF | 208,100 | $653,434 | 0.17% |
| 74 | REVIVA PHARMACEUTCLS HLDGS I | 76152G100 | 650,723 | $620,660 | 0.16% |
| 75 | EVOLUS INC | EOLS | 50,000 | $601,500 | 0.16% |
| 76 | ALECTOR INC | ALEC | 456,546 | $561,552 | 0.15% |
| 77 | VERVE THERAPEUTICS INC | 92539P101 | 116,900 | $534,233 | 0.14% |
| 78 | SUMMIT THERAPEUTICS INC | SMMT | 24,700 | $476,463 | 0.12% |
| 79 | NEKTAR THERAPEUTICS | NKTR | 678,200 | $461,176 | 0.12% |
| 80 | CASSAVA SCIENCES INC | 14817C107 | 300,000 | $450,000 | 0.12% |
| 81 | UNIQURE NV | QURE | 36,500 | $386,900 | 0.10% |
| 82 | COMPASS THERAPEUTICS INC | CMPX | 200,000 | $380,000 | 0.10% |
| 83 | OLEMA PHARMACEUTICALS INC | OLMA | 100,000 | $376,000 | 0.10% |
| 84 | BIOMEA FUSION INC | BMEA | 170,100 | $362,313 | 0.09% |
| 85 | UNITY BIOTECHNOLOGY INC | UNTCW | 346,900 | $360,776 | 0.09% |
| 86 | IMMUNIC INC | IMUX | 317,800 | $346,402 | 0.09% |
| 87 | RELAY THERAPEUTICS INC | RLAY | 131,400 | $344,268 | 0.09% |
| 88 | GOSSAMER BIO INC | GOSS | 269,589 | $296,548 | 0.08% |
| 89 | CAPRICOR THERAPEUTICS INC | CAPR | 30,300 | $287,547 | 0.08% |
| 90 | PROQR THRAPEUTICS N V | N71542109 | 207,694 | $276,233 | 0.07% |
| 91 | UNITY BIOTECHNOLOGY INC | UNTCW | 215,200 | $223,808 | 0.06% |
| 92 | ELEDON PHARMACEUTICALS INC | ELDN | 64,613 | $219,038 | 0.06% |
| 93 | MEREO BIOPHARMA GROUP PLC | MREO | 492,215 | $168,512 | 0.04% |
| 94 | ATYR PHARMA INC | ATYR | 54,700 | $165,194 | 0.04% |
| 95 | TERNS PHARMACEUTICALS INC | TERN | 56,098 | $154,830 | 0.04% |
| 96 | SAGIMET BIOSCIENCES INC | SGMT | 46,019 | $150,022 | 0.04% |
| 97 | CANDEL THERAPEUTICS INC | CADL | 25,045 | $141,504 | 0.04% |
| 98 | MEREO BIOPHARMA GROUP PLC | MREO | 39,400 | $88,650 | 0.02% |
| 99 | ATYR PHARMA INC | ATYR | 11,800 | $35,636 | 0.01% |
| 100 | CASSAVA SCIENCES INC | 14817C107 | 9,900 | $14,850 | 0.00% |
| 101 | JAZZ PHARMACEUTICALS PLC | JAZZ | 100 | $12,415 | 0.00% |
| 102 | VISTAGEN THERAPEUTICS INC | VTGN | 200 | $500 | 0.00% |